1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.3. Restraints
5.4. Opportunities
5.5. Challenges

6. Stem Cells Market, by Cell Source
6.1. Introduction
6.2. Adipose Tissue-Derived Mesenchymal Stem Cells
6.3. Bone Marrow-Derived Mesenchymal Stem Cells
6.4. Cord Blood/Embryonic Stem Cells

7. Stem Cells Market, by Type
7.1. Introduction
7.2. Allogeneic Stem Cell Therapy
7.2.1. Acute Graft-Versus-Host Disease
7.2.2. Musculoskeletal Disorders
7.2.3. Surgeries
7.2.4. Wounds and Injuries
7.3. Autologous
7.3.1. Cardiovascular Diseases
7.3.2. Gastrointestinal Diseases
7.3.3. Wounds and Injuries

8. Stem Cells Market, by Therapeutic Application
8.1. Introduction
8.2. Cardiovascular Diseases
8.3. Gastrointestinal Diseases
8.4. Musculoskeletal Disorders
8.5. Surgeries
8.6. Wounds and Injuries

9. California Stem Cells Market

10. Florida Stem Cells Market

11. Illinois Stem Cells Market

12. New York Stem Cells Market

13. Ohio Stem Cells Market

14. Pennsylvania Stem Cells Market

15. Texas Stem Cells Market

16. Competitive Landscape
16.1. FPNV Positioning Matrix
16.1.1. Quadrants
16.1.2. Business Strategy
16.1.3. Product Satisfaction
16.2. Market Ranking Analysis
16.3. Market Share Analysis, By Key Player
16.4. Competitive Scenario
16.4.1. Merger & Acquisition
16.4.2. Agreement, Collaboration, & Partnership
16.4.3. New Product Launch & Enhancement
16.4.4. Investment & Funding
16.4.5. Award, Recognition, & Expansion

17. Company Usability Profiles
17.1. AlloSource, Inc.
17.2. Anterogen Co., Ltd.
17.3. Athersys, Inc
17.4. BioRestorative Therapies
17.5. BrainStorm
17.6. Cellular Biomedicine Group, Inc.
17.7. CORESTEM Inc.
17.8. Gamida-Cell Ltd.
17.9. Holostem Terapie Avanzate Srl
17.10. Hope Biosciences
17.11. Kangstem Biotech
17.12. MEDIPOST Co., Ltd.
17.13. NuVasive, Inc.
17.14. Nuvasive, Inc.
17.15. Orthofix
17.16. Pharmicell Co.,Ltd.
17.17. Pluristem Therapeutics
17.18. RTI Surgical
17.19. RTI Surgical, Inc.
17.20. Smith & Nephew PLC
17.21. Stempeutics Research Pvt. Ltd.
17.22. Takeda Pharmaceutical Company Limited
17.23. ViaCyte

18. Appendix
18.1. Discussion Guide
18.2. License & Pricing

List of Figures

FIGURE 1. UNITED STATES STEM CELLS MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. UNITED STATES STEM CELLS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 3. UNITED STATES STEM CELLS MARKET: MARKET DYNAMICS
FIGURE 4. UNITED STATES STEM CELLS MARKET SIZE, BY CELL SOURCE, 2020 VS 2026 (%)
FIGURE 5. UNITED STATES STEM CELLS MARKET SIZE, BY CELL SOURCE, 2020 VS 2026 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES STEM CELLS MARKET SIZE, BY CELL SOURCE, 2026
FIGURE 7. UNITED STATES STEM CELLS MARKET SIZE, BY ADIPOSE TISSUE-DERIVED MESENCHYMAL STEM CELLS, 2018-2026 (USD MILLION)
FIGURE 8. UNITED STATES STEM CELLS MARKET SIZE, BY ADIPOSE TISSUE-DERIVED MESENCHYMAL STEM CELLS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 9. UNITED STATES STEM CELLS MARKET SIZE, BY BONE MARROW-DERIVED MESENCHYMAL STEM CELLS, 2018-2026 (USD MILLION)
FIGURE 10. UNITED STATES STEM CELLS MARKET SIZE, BY BONE MARROW-DERIVED MESENCHYMAL STEM CELLS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 11. UNITED STATES STEM CELLS MARKET SIZE, BY CORD BLOOD/EMBRYONIC STEM CELLS, 2018-2026 (USD MILLION)
FIGURE 12. UNITED STATES STEM CELLS MARKET SIZE, BY CORD BLOOD/EMBRYONIC STEM CELLS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 13. UNITED STATES STEM CELLS MARKET SIZE, BY TYPE, 2020 VS 2026 (%)
FIGURE 14. UNITED STATES STEM CELLS MARKET SIZE, BY TYPE, 2020 VS 2026 (USD MILLION)
FIGURE 15. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES STEM CELLS MARKET SIZE, BY TYPE, 2026
FIGURE 16. UNITED STATES STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2026 (USD MILLION)
FIGURE 17. UNITED STATES STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 18. UNITED STATES STEM CELLS MARKET SIZE, BY ACUTE GRAFT-VERSUS-HOST DISEASE, 2018-2026 (USD MILLION)
FIGURE 19. UNITED STATES STEM CELLS MARKET SIZE, BY ACUTE GRAFT-VERSUS-HOST DISEASE, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 20. UNITED STATES STEM CELLS MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, 2018-2026 (USD MILLION)
FIGURE 21. UNITED STATES STEM CELLS MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 22. UNITED STATES STEM CELLS MARKET SIZE, BY SURGERIES, 2018-2026 (USD MILLION)
FIGURE 23. UNITED STATES STEM CELLS MARKET SIZE, BY SURGERIES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 24. UNITED STATES STEM CELLS MARKET SIZE, BY WOUNDS AND INJURIES, 2018-2026 (USD MILLION)
FIGURE 25. UNITED STATES STEM CELLS MARKET SIZE, BY WOUNDS AND INJURIES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 26. UNITED STATES STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2026 (USD MILLION)
FIGURE 27. UNITED STATES STEM CELLS MARKET SIZE, BY AUTOLOGOUS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 28. UNITED STATES STEM CELLS MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2026 (USD MILLION)
FIGURE 29. UNITED STATES STEM CELLS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 30. UNITED STATES STEM CELLS MARKET SIZE, BY GASTROINTESTINAL DISEASES, 2018-2026 (USD MILLION)
FIGURE 31. UNITED STATES STEM CELLS MARKET SIZE, BY GASTROINTESTINAL DISEASES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 32. UNITED STATES STEM CELLS MARKET SIZE, BY WOUNDS AND INJURIES, 2018-2026 (USD MILLION)
FIGURE 33. UNITED STATES STEM CELLS MARKET SIZE, BY WOUNDS AND INJURIES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 34. UNITED STATES STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION , 2020 VS 2026 (%)
FIGURE 35. UNITED STATES STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION , 2020 VS 2026 (USD MILLION)
FIGURE 36. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION , 2026
FIGURE 37. UNITED STATES STEM CELLS MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2026 (USD MILLION)
FIGURE 38. UNITED STATES STEM CELLS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 39. UNITED STATES STEM CELLS MARKET SIZE, BY GASTROINTESTINAL DISEASES, 2018-2026 (USD MILLION)
FIGURE 40. UNITED STATES STEM CELLS MARKET SIZE, BY GASTROINTESTINAL DISEASES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 41. UNITED STATES STEM CELLS MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, 2018-2026 (USD MILLION)
FIGURE 42. UNITED STATES STEM CELLS MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 43. UNITED STATES STEM CELLS MARKET SIZE, BY SURGERIES, 2018-2026 (USD MILLION)
FIGURE 44. UNITED STATES STEM CELLS MARKET SIZE, BY SURGERIES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 45. UNITED STATES STEM CELLS MARKET SIZE, BY WOUNDS AND INJURIES, 2018-2026 (USD MILLION)
FIGURE 46. UNITED STATES STEM CELLS MARKET SIZE, BY WOUNDS AND INJURIES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 47. UNITED STATES STEM CELLS MARKET: FPNV POSITIONING MATRIX
FIGURE 48. UNITED STATES STEM CELLS MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 49. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES STEM CELLS MARKET, BY TYPE

List of Tables

TABLE 1. UNITED STATES STEM CELLS MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. UNITED STATES STEM CELLS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. UNITED STATES STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2026 (USD MILLION)
TABLE 5. UNITED STATES STEM CELLS MARKET SIZE, BY ADIPOSE TISSUE-DERIVED MESENCHYMAL STEM CELLS, BY STATE, 2018-2026 (USD MILLION)
TABLE 6. UNITED STATES STEM CELLS MARKET SIZE, BY BONE MARROW-DERIVED MESENCHYMAL STEM CELLS, BY STATE, 2018-2026 (USD MILLION)
TABLE 7. UNITED STATES STEM CELLS MARKET SIZE, BY CORD BLOOD/EMBRYONIC STEM CELLS, BY STATE, 2018-2026 (USD MILLION)
TABLE 8. UNITED STATES STEM CELLS MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 9. UNITED STATES STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, BY STATE, 2018-2026 (USD MILLION)
TABLE 10. UNITED STATES STEM CELLS MARKET SIZE, BY ACUTE GRAFT-VERSUS-HOST DISEASE, BY STATE, 2018-2026 (USD MILLION)
TABLE 11. UNITED STATES STEM CELLS MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, BY STATE, 2018-2026 (USD MILLION)
TABLE 12. UNITED STATES STEM CELLS MARKET SIZE, BY SURGERIES, BY STATE, 2018-2026 (USD MILLION)
TABLE 13. UNITED STATES STEM CELLS MARKET SIZE, BY WOUNDS AND INJURIES, BY STATE, 2018-2026 (USD MILLION)
TABLE 14. UNITED STATES STEM CELLS MARKET SIZE, BY AUTOLOGOUS, BY STATE, 2018-2026 (USD MILLION)
TABLE 15. UNITED STATES STEM CELLS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY STATE, 2018-2026 (USD MILLION)
TABLE 16. UNITED STATES STEM CELLS MARKET SIZE, BY GASTROINTESTINAL DISEASES, BY STATE, 2018-2026 (USD MILLION)
TABLE 17. UNITED STATES STEM CELLS MARKET SIZE, BY WOUNDS AND INJURIES, BY STATE, 2018-2026 (USD MILLION)
TABLE 18. UNITED STATES STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION , 2018-2026 (USD MILLION)
TABLE 19. UNITED STATES STEM CELLS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY STATE, 2018-2026 (USD MILLION)
TABLE 20. UNITED STATES STEM CELLS MARKET SIZE, BY GASTROINTESTINAL DISEASES, BY STATE, 2018-2026 (USD MILLION)
TABLE 21. UNITED STATES STEM CELLS MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, BY STATE, 2018-2026 (USD MILLION)
TABLE 22. UNITED STATES STEM CELLS MARKET SIZE, BY SURGERIES, BY STATE, 2018-2026 (USD MILLION)
TABLE 23. UNITED STATES STEM CELLS MARKET SIZE, BY WOUNDS AND INJURIES, BY STATE, 2018-2026 (USD MILLION)
TABLE 24. UNITED STATES STEM CELLS MARKET: SCORES
TABLE 25. UNITED STATES STEM CELLS MARKET: BUSINESS STRATEGY
TABLE 26. UNITED STATES STEM CELLS MARKET: PRODUCT SATISFACTION
TABLE 27. UNITED STATES STEM CELLS MARKET: RANKING
TABLE 28. UNITED STATES STEM CELLS MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 29. UNITED STATES STEM CELLS MARKET: MERGER & ACQUISITION
TABLE 30. UNITED STATES STEM CELLS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 31. UNITED STATES STEM CELLS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 32. UNITED STATES STEM CELLS MARKET: INVESTMENT & FUNDING
TABLE 33. UNITED STATES STEM CELLS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 34. UNITED STATES STEM CELLS MARKET: LICENSE & PRICING

Companies Mentioned

AlloSource, Inc.
Anterogen Co., Ltd.
Athersys, Inc
BioRestorative Therapies
BrainStorm
Cellular Biomedicine Group, Inc.
CORESTEM Inc.
Gamida-Cell Ltd.
Holostem Terapie Avanzate Srl
Hope Biosciences
Kangstem Biotech
MEDIPOST Co., Ltd.
NuVasive, Inc.
Nuvasive, Inc.
Orthofix
Pharmicell Co.,Ltd.
Pluristem Therapeutics
RTI Surgical
RTI Surgical, Inc.
Smith & Nephew PLC
Stempeutics Research Pvt. Ltd.
Takeda Pharmaceutical Company Limited
ViaCyte